GENE ONLINE|News &
Opinion
Blog

TNBC
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
R&D
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
Roche’s Multifaceted Drug, Tecentriq Registers Mixed Results in Breast Cancer Patients
2020-09-22
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
R&D
ASCO 2020: Keytruda Chemo Combo Show Significant Benefit in PD-L1 Expressing mTNBC
2020-06-03
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top